Background illustration for clinical trials search

Paid Clinical Trials Edmond

Discover 575 paid clinical trials in Edmond, Oklahoma. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer

for
Pancreatic Cancer, Metastatic Pancreatic Cancer,
Location: Oklahoma City OK, Fort Smith AR, Dallas TX,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT07409272

Phase3, Recruiting

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

for
Cutaneous Melanoma, Stage II
Location: Oklahoma City OK, Springfield MO, Overland Park KS,
Sponsor: Melanoma and Skin Cancer Trials Limited

Sex: All

Age: 18+

Code: NCT03860883

Recruiting
New

A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease

for
Sjögren's Disease
Location: Oklahoma City OK, Bellaire TX, Tampa FL, Sherbrooke
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07737743

Phase2, Recruiting

A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis

for
Arthritis, Psoriatic
Location: Oklahoma City OK, Frisco TX, Irving TX, Dallas TX,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06807424

Phase3, Recruiting

A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]

for
Myositis
Location: Oklahoma City OK, Frisco TX, Katy TX, Houston TX,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT05895786

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Proton and Photon Consortium Registry (PPCR): A Multi Center Registry of Pediatric Patients Treated With Radiation Therapy

for
Pediatric Patients Treated With Radiation Therapy
Location: Oklahoma City OK, Irving TX, Houston TX, St Louis MO,
Sponsor: Massachusetts General Hospital

Sex: All

Age: 0 - 21

Code: NCT01696721

Recruiting

Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer

for
Prostate Cancer
Location: Oklahoma City OK, Warrenville IL, Scottsdale AZ,
Sponsor: Proton Collaborative Group

Sex: Male

Age: 18+

Code: NCT01492972

Phase3, Recruiting

Registry Study for Radiation Therapy Outcomes

for
Neoplasms
Location: Oklahoma City OK, Irving TX, Kansas City KS,
Sponsor: Proton Collaborative Group

Sex: All

Age: 0+

Code: NCT01255748

Recruiting

A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

for
Graves' Disease
Location: Oklahoma City OK, McKinney TX, Irving TX, Fort Worth TX,
Sponsor: Immunovant Sciences GmbH

Sex: All

Age: 18 - 70+

Code: NCT07018323

Phase2, Recruiting

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

for
Non-small Cell Lung Cancer
Location: Oklahoma City OK, Hastings NE, Columbia MO, Fenton MO,
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT06712316

Phase2, Phase3, Recruiting

A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia

for
Primary Immune Thrombocytopenia (ITP)
Location: Oklahoma City OK, Aurora CO, Iowa City IA,
Sponsor: argenx

Sex: All

Age: 18+

Code: NCT06544499

Phase3, Recruiting

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

for
Advanced Lung Non-Squamous Non-Small Cell Carcinoma,
Location: Oklahoma City OK, Wichita KS, Dallas TX, Lincoln NE,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT04181060

Phase3, Recruiting
New

A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age

for
Influenza, Human
Location: Oklahoma City OK, Chickasha OK, Tulsa OK, McKinney TX,
Sponsor: GlaxoSmithKline

Sex: All

Age: 65+

Code: NCT07805707

Phase3, Recruiting

Artificial Intelligence to Measure Adherence to Oral Medication

for
First Episode Psychosis
Location: Oklahoma City OK, Tulsa OK, Kalamazoo MI,
Sponsor: Northwell Health

Sex: All

Age: 15 - 40

Code: NCT04046497

Recruiting

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

for
Generalized Myasthenia Gravis
Location: Oklahoma City OK, Yukon OK, Denton TX, Dallas TX,
Sponsor: Immunovant Sciences GmbH

Sex: All

Age: 18 - 70+

Code: NCT07039916

Phase3, Recruiting

Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder

for
Generalized Anxiety Disorder
Location: Oklahoma City OK, Rogers AR, Dallas TX, Little Rock AR,
Sponsor: Intra-Cellular Therapies, Inc.

Sex: All

Age: 18+

Code: NCT06701903

Phase2, Recruiting

Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder

for
Schizophrenia, Bipolar Disorder, Autism Spectrum Disorder
Location: Oklahoma City OK, Plano TX, Coppell TX, Fort Worth TX,
Sponsor: Intra-Cellular Therapies, Inc.

Sex: All

Age: 5 - 17

Code: NCT06229210

Phase3, Recruiting

Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder (ASD) in Pediatric Patients

for
Irritability Associated With Autism Spectrum Disorder
Location: Oklahoma City OK, Coppell TX, Little Rock AR,
Sponsor: Intra-Cellular Therapies, Inc.

Sex: All

Age: 5 - 17

Code: NCT06706674

Phase3, Recruiting

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)

for
Major Depressive Disorder
Location: Oklahoma City OK, Bentonville AR, Bryant AR, Austin TX,
Sponsor: Xenon Pharmaceuticals Inc.

Sex: All

Age: 18 - 70+

Code: NCT07076407

Phase3, Recruiting

Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder

for
Generalized Anxiety Disorder
Location: Oklahoma City OK, Plano TX, Austin TX, Atlanta GA,
Sponsor: Intra-Cellular Therapies, Inc.

Sex: All

Age: 0+

Code: NCT06480383

Phase2, Recruiting